Angelo Musicò

This paper develops a nanoplatform using red blood cell-derived extracellular vesicles to deliver Cetuximab and cisplatin, enhancing cancer cell killing and reducing toxicity in triple-negative breast cancer.

This paper introduces a membrane-sensing peptide-based method for isolating urinary extracellular vesicles, showing improved purity, reduced contaminants, and better scalability compared to traditional methods.

This study uses freezing-induced aging to produce homogeneous RBC-EVs, demonstrating improved functionality and storage stability for EV-based nanomedicine.